Convergen

Seed
convergenbio.com Biotech & Healthcare Suzhou, China
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Aug 31, 2026
Investors Undisclosed
Decision Makers Profile Active

About Convergen

Convergen develops targeted protein degradation therapies for diseases associated with pathological protein aggregates.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Suzhou, China
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website convergenbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Convergen.

Funding History

1 Round
Seed · Aug 31, 2026
Undisclosed

Founders & Leadership

1

Jinquan Sun

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts